Jolt

Jolt Health is a Canadian public life sciences and health-and-wellness company listed on the Canadian Securities Exchange under the symbol JOLT. The company describes itself as a specialized licensee and distributor of pharmaceutical and therapeutic products, with historical emphasis on mental health, sexual wellness, and cannabinoid- or psychedelic-adjacent wellness products. More recently, Jolt has highlighted biotechnology assets tied to transdermal and oral mucosal delivery intellectual property for hydroxychloroquine and chloroquine, which it has described as relevant to autoimmune disease and malaria applications. Based on public disclosures, the company appears to be at an early, preclinical or IP-commercialization stage rather than an advanced clinical development-stage biotech. It has a small corporate footprint, limited disclosed pipeline detail, and remains oriented around licensing, product rights, and capital markets activity.